EBD RCT Trial in Living Donor Liver Transplantation (NCT04622540) | Clinical Trial Compass
RecruitingNot Applicable
EBD RCT Trial in Living Donor Liver Transplantation
South Korea124 participantsStarted 2020-12-09
Plain-language summary
This study was designed to demonstrate incidence of biliary complication rates after living donor liver transplantation according to the implantation of external biliary drainage throug duct-to-duct anastomosis site.
Who can participate
Age range
19 Years – 79 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Living donor liver transplantation
* Adult patient (\>=18 years old)
* Patients who are available for at least 3 year follow-up after LDLT
Exclusion Criteria:
* Patients requring hepaticojejunostomy due to anatomical factor or underlying disease
* Re-transplantation
* Multiorgan transplantation
* Emergency transplantation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focused on biliary complications like bile leaks and strictures after living donor liver transplant — how common are these complications in my situation, and is being in this study likely to change how my bile duct is managed compared to standard care?
2Since this trial doesn't have a traditional phase label, what does that mean for how much is already known about the safety of whatever technique or intervention is being compared here — and how does that affect the risk to me as a participant?
3The study is measuring biliary complications over the first full year after transplant — if I enroll, what kind of follow-up appointments or monitoring would I need during that year, and would that fit with my current care plan?
4Because this involves living donor liver transplantation specifically, could participating in this trial affect any decisions about my donor's surgery, or is the study intervention only on the recipient side?
5Given that this trial is still actively recruiting, would you recommend I consider this now, or would it make more sense to discuss it after we've decided whether living donor transplant is the right path for me?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence of biliary complication within 1 year after LDLT